Regnante Keith — SEC Form 4 filings

SEC reporting owner CIK 1682068. 6 Form 4 filings on record with FilingPulse; latest filed 2026-02-26.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-01-08 to 2026-02-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Keros Therapeutics, Inc. (KROS)CHIEF FINANCIAL OFFICER63 legs · 84,739 sh · $3,700,6836

Form 4 filings — Regnante Keith

FiledFormIssuerReported transactionsSource
2026-02-264Keros Therapeutics, Inc. (KROS)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2026-02-204Keros Therapeutics, Inc. (KROS)Sale (S): 4,739 @ $16.35EDGAR
2025-02-194Keros Therapeutics, Inc. (KROS)Grant/award (A): 44,000 @ $0EDGAR
2025-01-244/AKeros Therapeutics, Inc. (KROS)Option exercise (M): 40,000 @ $16 · Sale (S): 40,000 @ $45.29EDGAR
2024-02-154Keros Therapeutics, Inc. (KROS)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-01-084Keros Therapeutics, Inc. (KROS)Option exercise (M): 40,000 @ $16 · Sale (S): 40,000 @ $45.29 · Option exercise (M): 40,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-04 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1682068 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →